

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glucose 6-phosphate metabolic process (GO:0051156) | 5.39228402 |
| 2 | leukocyte aggregation (GO:0070486) | 5.21687261 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.13252851 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.09167853 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.09167853 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.09167853 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.09167853 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.09167853 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.09167853 |
| 10 | plasma lipoprotein particle assembly (GO:0034377) | 4.79951054 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.76210999 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.68938809 |
| 13 | cellular extravasation (GO:0045123) | 4.62662954 |
| 14 | detection of external biotic stimulus (GO:0098581) | 4.58105553 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51451691 |
| 16 | response to peptidoglycan (GO:0032494) | 4.48215720 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.46039824 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.32679373 |
| 19 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.31659157 |
| 20 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.26498503 |
| 21 | neutrophil mediated immunity (GO:0002446) | 4.21714222 |
| 22 | respiratory burst (GO:0045730) | 4.17289033 |
| 23 | histone H3-K9 demethylation (GO:0033169) | 4.16503011 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16205653 |
| 25 | positive regulation of mast cell activation (GO:0033005) | 4.15986141 |
| 26 | protein-lipid complex assembly (GO:0065005) | 4.14312590 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.10009739 |
| 28 | response to host immune response (GO:0052572) | 4.10009739 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 4.01356779 |
| 30 | detection of biotic stimulus (GO:0009595) | 4.01281813 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99045195 |
| 32 | neutrophil activation (GO:0042119) | 3.97964746 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95543727 |
| 34 | response to host (GO:0075136) | 3.95543727 |
| 35 | response to host defenses (GO:0052200) | 3.95543727 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.86447698 |
| 37 | peptidyl-proline hydroxylation (GO:0019511) | 3.80872599 |
| 38 | regulation of leukocyte degranulation (GO:0043300) | 3.75507848 |
| 39 | regulation of mast cell activation (GO:0033003) | 3.72069053 |
| 40 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.71984979 |
| 41 | * glycolytic process (GO:0006096) | 3.71282598 |
| 42 | defense response to fungus (GO:0050832) | 3.69329144 |
| 43 | 4-hydroxyproline metabolic process (GO:0019471) | 3.65987582 |
| 44 | granulocyte activation (GO:0036230) | 3.63400014 |
| 45 | microglial cell activation (GO:0001774) | 3.60601661 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60302800 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.58648473 |
| 48 | response to fungus (GO:0009620) | 3.53646654 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.47891341 |
| 50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.47891341 |
| 51 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.46600850 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.42568696 |
| 53 | response to interleukin-15 (GO:0070672) | 3.39920079 |
| 54 | regulation of cellular amide metabolic process (GO:0034248) | 3.39190626 |
| 55 | negative regulation of cell killing (GO:0031342) | 3.34350820 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34350820 |
| 57 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.29323038 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28373853 |
| 59 | regulation of regulated secretory pathway (GO:1903305) | 3.24906402 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 3.24718027 |
| 61 | detection of other organism (GO:0098543) | 3.22548709 |
| 62 | leukotriene metabolic process (GO:0006691) | 3.21557773 |
| 63 | neutrophil chemotaxis (GO:0030593) | 3.20856534 |
| 64 | myeloid leukocyte mediated immunity (GO:0002444) | 3.19802554 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 3.14048529 |
| 66 | angiotensin maturation (GO:0002003) | 3.11827860 |
| 67 | neutrophil migration (GO:1990266) | 3.10730611 |
| 68 | negative regulation of interleukin-12 production (GO:0032695) | 3.06725105 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.06571659 |
| 70 | positive regulation of leukocyte degranulation (GO:0043302) | 3.05690021 |
| 71 | negative regulation of mast cell activation (GO:0033004) | 3.03719995 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01057999 |
| 73 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00986086 |
| 74 | protein hydroxylation (GO:0018126) | 3.00262386 |
| 75 | macrophage differentiation (GO:0030225) | 2.99150516 |
| 76 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.96829539 |
| 77 | detection of bacterium (GO:0016045) | 2.95753120 |
| 78 | skeletal muscle adaptation (GO:0043501) | 2.95750628 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93398758 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 2.92075928 |
| 81 | regulation of superoxide anion generation (GO:0032928) | 2.91404968 |
| 82 | phospholipid efflux (GO:0033700) | 2.91078942 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90880000 |
| 84 | actin nucleation (GO:0045010) | 2.89707841 |
| 85 | leukocyte cell-cell adhesion (GO:0007159) | 2.89028286 |
| 86 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88388712 |
| 87 | leukocyte mediated cytotoxicity (GO:0001909) | 2.87469357 |
| 88 | histone H3-K36 demethylation (GO:0070544) | 2.86862903 |
| 89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.86069860 |
| 90 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85143762 |
| 91 | granulocyte chemotaxis (GO:0071621) | 2.85036210 |
| 92 | phagosome maturation (GO:0090382) | 2.83565803 |
| 93 | oligosaccharide catabolic process (GO:0009313) | 2.83003471 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.81557432 |
| 95 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80616682 |
| 96 | leukotriene biosynthetic process (GO:0019370) | 2.78481630 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77909184 |
| 98 | sequestering of metal ion (GO:0051238) | 2.77568278 |
| 99 | response to laminar fluid shear stress (GO:0034616) | 2.77496231 |
| 100 | cellular response to type I interferon (GO:0071357) | 2.77487570 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.77487570 |
| 102 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.76782542 |
| 103 | histone lysine demethylation (GO:0070076) | 2.76699219 |
| 104 | macrophage activation (GO:0042116) | 2.76614057 |
| 105 | granulocyte migration (GO:0097530) | 2.76461704 |
| 106 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74956058 |
| 107 | barbed-end actin filament capping (GO:0051016) | 2.74372848 |
| 108 | regulation of B cell differentiation (GO:0045577) | 2.74248675 |
| 109 | cholesterol efflux (GO:0033344) | 2.72137311 |
| 110 | response to type I interferon (GO:0034340) | 2.71906649 |
| 111 | histone demethylation (GO:0016577) | 2.69660934 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69313779 |
| 113 | intestinal absorption (GO:0050892) | 2.67096666 |
| 114 | anatomical structure regression (GO:0060033) | 2.66934984 |
| 115 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.65469978 |
| 116 | T-helper 1 type immune response (GO:0042088) | 2.65283806 |
| 117 | negative regulation of interleukin-6 production (GO:0032715) | 2.64941109 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.64266019 |
| 119 | peptide catabolic process (GO:0043171) | 2.62918361 |
| 120 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62558854 |
| 121 | diacylglycerol metabolic process (GO:0046339) | 2.61762915 |
| 122 | alpha-linolenic acid metabolic process (GO:0036109) | 2.60827623 |
| 123 | positive regulation of p38MAPK cascade (GO:1900745) | 2.60177323 |
| 124 | germinal center formation (GO:0002467) | 2.59716431 |
| 125 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58654486 |
| 126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58301667 |
| 127 | lipoprotein transport (GO:0042953) | 2.56271331 |
| 128 | negative regulation of phagocytosis (GO:0050765) | 2.55290039 |
| 129 | plasma lipoprotein particle organization (GO:0071827) | 2.54870818 |
| 130 | regulation of activation of Janus kinase activity (GO:0010533) | 2.53991314 |
| 131 | adhesion of symbiont to host cell (GO:0044650) | 2.53574699 |
| 132 | virion attachment to host cell (GO:0019062) | 2.53574699 |
| 133 | regulation of podosome assembly (GO:0071801) | 2.52174912 |
| 134 | leukocyte degranulation (GO:0043299) | 2.50989669 |
| 135 | B cell receptor signaling pathway (GO:0050853) | 2.49318214 |
| 136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.46946305 |
| 137 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46347524 |
| 138 | lipoxygenase pathway (GO:0019372) | 2.45297294 |
| 139 | positive regulation of regulated secretory pathway (GO:1903307) | 2.44706667 |
| 140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.44125472 |
| 141 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.43383056 |
| 142 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42563094 |
| 143 | actin filament depolymerization (GO:0030042) | 2.42516604 |
| 144 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.41065373 |
| 145 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.41065373 |
| 146 | surfactant homeostasis (GO:0043129) | 2.40082560 |
| 147 | mannose metabolic process (GO:0006013) | 2.39525889 |
| 148 | positive regulation of B cell differentiation (GO:0045579) | 2.38513707 |
| 149 | dendritic cell migration (GO:0036336) | 2.36912556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.83990670 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.45182830 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45407329 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.35318475 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32308842 |
| 6 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.25297912 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.17058653 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97413530 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89434177 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.85142991 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64065890 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.62136573 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.48546089 |
| 14 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35424584 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.34764634 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23653107 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03681171 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03521769 |
| 19 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.01313524 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.00768252 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00491418 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00372075 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00167384 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92406745 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87383301 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.83837814 |
| 27 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.83812623 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.74654561 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72358048 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71961786 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66508332 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65009330 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63722984 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63440040 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.61464424 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61407617 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61025563 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.60630288 |
| 39 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.60086440 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59778541 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57707248 |
| 42 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56102366 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55618996 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54835315 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.53233596 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52987075 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52471598 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52063424 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.50278012 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49425351 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45087233 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44306132 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42744649 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.42418478 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41970562 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40279330 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37692134 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37040930 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36942619 |
| 60 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36591474 |
| 61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35760278 |
| 62 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34447057 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33920376 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33831382 |
| 65 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.32362089 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32158300 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32103536 |
| 68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30726015 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30186722 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29377700 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28354368 |
| 72 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.26849890 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26681050 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26418526 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24974388 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24852095 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24327288 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.24079681 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23662781 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23210511 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23111678 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22453391 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21902706 |
| 84 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.21785277 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21590376 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20843397 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20741932 |
| 88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20420670 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19697225 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16547850 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14832020 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14479755 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14315234 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14185777 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14106509 |
| 96 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13556700 |
| 97 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13444335 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13435185 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12943908 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11340121 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11069559 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10438153 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 1.09687356 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09395921 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08600133 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06607105 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06265571 |
| 108 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.05486218 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05444038 |
| 110 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04284189 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04245957 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04227811 |
| 113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03642375 |
| 114 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03472025 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02628558 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00423129 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99993551 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99961186 |
| 119 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99766607 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97157816 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97009595 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96284280 |
| 123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95092728 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94018853 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93745333 |
| 126 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92821708 |
| 127 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92105464 |
| 128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91536705 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91152575 |
| 130 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90315061 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89833863 |
| 132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88711068 |
| 133 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88481390 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88381026 |
| 135 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86568855 |
| 136 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86206716 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85188670 |
| 138 | MAF_26560356_Chip-Seq_TH2_Human | 0.84033761 |
| 139 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83355347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.84963959 |
| 2 | MP0003183_abnormal_peptide_metabolism | 3.75980810 |
| 3 | MP0003436_decreased_susceptibility_to | 3.69408122 |
| 4 | MP0003303_peritoneal_inflammation | 3.40557455 |
| 5 | MP0005451_abnormal_body_composition | 2.99608354 |
| 6 | MP0002419_abnormal_innate_immunity | 2.95947796 |
| 7 | MP0003122_maternal_imprinting | 2.92442282 |
| 8 | MP0003878_abnormal_ear_physiology | 2.82031938 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.82031938 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.81002200 |
| 11 | MP0002132_abnormal_respiratory_system | 2.67844987 |
| 12 | MP0009785_altered_susceptibility_to | 2.61716871 |
| 13 | MP0005360_urolithiasis | 2.51241923 |
| 14 | MP0009278_abnormal_bone_marrow | 2.50812858 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.27361359 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.26047787 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.25989563 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.22697697 |
| 19 | MP0005025_abnormal_response_to | 2.22280845 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.22227752 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 2.20085305 |
| 22 | MP0001790_abnormal_immune_system | 2.18596025 |
| 23 | MP0005387_immune_system_phenotype | 2.18596025 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.18499867 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.16964446 |
| 26 | MP0005408_hypopigmentation | 2.15978217 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.13934511 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.12655468 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 2.07869300 |
| 30 | MP0003724_increased_susceptibility_to | 2.00165983 |
| 31 | MP0009840_abnormal_foam_cell | 1.97232667 |
| 32 | MP0001819_abnormal_immune_cell | 1.91498110 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.90215956 |
| 34 | MP0000343_altered_response_to | 1.88467936 |
| 35 | MP0002723_abnormal_immune_serum | 1.86344794 |
| 36 | MP0002405_respiratory_system_inflammati | 1.84301647 |
| 37 | MP0001800_abnormal_humoral_immune | 1.84071143 |
| 38 | MP0000685_abnormal_immune_system | 1.80712755 |
| 39 | MP0003075_altered_response_to | 1.79444152 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.78698486 |
| 41 | MP0003123_paternal_imprinting | 1.75840173 |
| 42 | MP0004510_myositis | 1.75663650 |
| 43 | MP0001873_stomach_inflammation | 1.70163391 |
| 44 | MP0004381_abnormal_hair_follicle | 1.68313716 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.67326893 |
| 46 | MP0001958_emphysema | 1.63813061 |
| 47 | MP0006082_CNS_inflammation | 1.60859525 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.58687784 |
| 49 | MP0005410_abnormal_fertilization | 1.57665155 |
| 50 | MP0005310_abnormal_salivary_gland | 1.57285805 |
| 51 | MP0002933_joint_inflammation | 1.56034798 |
| 52 | MP0004947_skin_inflammation | 1.54871873 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.52865236 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.51429314 |
| 55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.51408955 |
| 56 | MP0005166_decreased_susceptibility_to | 1.48752407 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.47201405 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.39971613 |
| 59 | MP0001853_heart_inflammation | 1.39104862 |
| 60 | MP0004130_abnormal_muscle_cell | 1.36855959 |
| 61 | MP0009764_decreased_sensitivity_to | 1.32038312 |
| 62 | MP0000371_diluted_coat_color | 1.30319652 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.29271982 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.29271982 |
| 65 | MP0000604_amyloidosis | 1.29072260 |
| 66 | MP0001663_abnormal_digestive_system | 1.28780145 |
| 67 | MP0000716_abnormal_immune_system | 1.27464888 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.26917922 |
| 69 | MP0005671_abnormal_response_to | 1.26560112 |
| 70 | MP0001851_eye_inflammation | 1.25738809 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.25395376 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.23626235 |
| 73 | MP0003448_altered_tumor_morphology | 1.23600641 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.23567386 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.19811439 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.18625881 |
| 77 | MP0000858_altered_metastatic_potential | 1.17831947 |
| 78 | MP0005085_abnormal_gallbladder_physiolo | 1.15865236 |
| 79 | MP0002928_abnormal_bile_duct | 1.15061726 |
| 80 | MP0008469_abnormal_protein_level | 1.13883766 |
| 81 | MP0000749_muscle_degeneration | 1.13525750 |
| 82 | MP0003121_genomic_imprinting | 1.12779396 |
| 83 | MP0003866_abnormal_defecation | 1.10604224 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.10528226 |
| 85 | MP0000678_abnormal_parathyroid_gland | 1.09941713 |
| 86 | MP0002398_abnormal_bone_marrow | 1.08372809 |
| 87 | MP0003690_abnormal_glial_cell | 1.08144121 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.04599600 |
| 89 | MP0001849_ear_inflammation | 1.04239220 |
| 90 | MP0000609_abnormal_liver_physiology | 1.04032519 |
| 91 | MP0003252_abnormal_bile_duct | 1.03776624 |
| 92 | MP0010329_abnormal_lipoprotein_level | 1.03667711 |
| 93 | MP0008260_abnormal_autophagy | 1.02795816 |
| 94 | MP0003315_abnormal_perineum_morphology | 1.01535723 |
| 95 | MP0008961_abnormal_basal_metabolism | 1.01052067 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 1.00811661 |
| 97 | MP0002429_abnormal_blood_cell | 0.99189812 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.97632070 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.97067369 |
| 100 | MP0001666_abnormal_nutrient_absorption | 0.96510349 |
| 101 | MP0003279_aneurysm | 0.96101653 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.95803261 |
| 103 | MP0008995_early_reproductive_senescence | 0.93721346 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.93573575 |
| 105 | MP0001915_intracranial_hemorrhage | 0.90981557 |
| 106 | MP0003566_abnormal_cell_adhesion | 0.89758756 |
| 107 | MP0005365_abnormal_bile_salt | 0.88841634 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 0.86307182 |
| 109 | MP0002722_abnormal_immune_system | 0.85309365 |
| 110 | MP0002971_abnormal_brown_adipose | 0.85028868 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.84345358 |
| 112 | MP0000920_abnormal_myelination | 0.82998894 |
| 113 | MP0005390_skeleton_phenotype | 0.82383933 |
| 114 | MP0005164_abnormal_response_to | 0.80561816 |
| 115 | MP0000747_muscle_weakness | 0.80137621 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.79974803 |
| 117 | MP0004858_abnormal_nervous_system | 0.79029695 |
| 118 | MP0003828_pulmonary_edema | 0.78091222 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.76291976 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.75968816 |
| 121 | MP0005409_darkened_coat_color | 0.75346788 |
| 122 | MP0004272_abnormal_basement_membrane | 0.74101028 |
| 123 | MP0005023_abnormal_wound_healing | 0.73315786 |
| 124 | MP0002075_abnormal_coat/hair_pigmentati | 0.72471592 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.72367414 |
| 126 | MP0004883_abnormal_blood_vessel | 0.72147841 |
| 127 | MP0005388_respiratory_system_phenotype | 0.71557923 |
| 128 | MP0002133_abnormal_respiratory_system | 0.71557923 |
| 129 | MP0002139_abnormal_hepatobiliary_system | 0.71374391 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.70729331 |
| 131 | MP0003091_abnormal_cell_migration | 0.70409279 |
| 132 | MP0002006_tumorigenesis | 0.70311321 |
| 133 | MP0005083_abnormal_biliary_tract | 0.69360191 |
| 134 | MP0000490_abnormal_crypts_of | 0.68895893 |
| 135 | MP0003045_fibrosis | 0.68706449 |
| 136 | MP0003795_abnormal_bone_structure | 0.68526595 |
| 137 | MP0003329_amyloid_beta_deposits | 0.67919679 |
| 138 | MP0000249_abnormal_blood_vessel | 0.67820685 |
| 139 | MP0005257_abnormal_intraocular_pressure | 0.67492253 |
| 140 | MP0004145_abnormal_muscle_electrophysio | 0.66525673 |
| 141 | MP0010234_abnormal_vibrissa_follicle | 0.66191539 |
| 142 | MP0001186_pigmentation_phenotype | 0.65396886 |
| 143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64197609 |
| 144 | MP0000598_abnormal_liver_morphology | 0.62087426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.29360097 |
| 2 | Cholecystitis (HP:0001082) | 6.25979653 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 6.25979653 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.68089230 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.35251592 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.49811724 |
| 7 | Interstitial pulmonary disease (HP:0006530) | 4.23220584 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.03000193 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.98142029 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.86638396 |
| 11 | Gingivitis (HP:0000230) | 3.71764529 |
| 12 | Obstructive lung disease (HP:0006536) | 3.68487141 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.68487141 |
| 14 | Optic neuritis (HP:0100653) | 3.61710642 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.58099520 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.56263950 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.45363373 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.24312528 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.21681634 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 3.15487407 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.10040741 |
| 22 | Recurrent skin infections (HP:0001581) | 3.08604967 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.07427269 |
| 24 | Reticulocytosis (HP:0001923) | 2.98327306 |
| 25 | Myositis (HP:0100614) | 2.98088658 |
| 26 | Cellulitis (HP:0100658) | 2.97867599 |
| 27 | Amyloidosis (HP:0011034) | 2.92899919 |
| 28 | Myopathic facies (HP:0002058) | 2.92343593 |
| 29 | Peritonitis (HP:0002586) | 2.88997936 |
| 30 | Spontaneous hematomas (HP:0007420) | 2.84608707 |
| 31 | Distal arthrogryposis (HP:0005684) | 2.83655633 |
| 32 | Hematochezia (HP:0002573) | 2.81134243 |
| 33 | Muscle fiber inclusion bodies (HP:0100299) | 2.79842232 |
| 34 | Frequent falls (HP:0002359) | 2.78332398 |
| 35 | Gingival bleeding (HP:0000225) | 2.75361472 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.74354513 |
| 37 | Periodontitis (HP:0000704) | 2.73678961 |
| 38 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.71138879 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 2.67225272 |
| 40 | Colitis (HP:0002583) | 2.64209088 |
| 41 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.64097384 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.59752771 |
| 43 | Hyperkalemia (HP:0002153) | 2.59487790 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58552485 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58552485 |
| 46 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58552485 |
| 47 | Loss of speech (HP:0002371) | 2.57259964 |
| 48 | Exercise-induced myalgia (HP:0003738) | 2.55507376 |
| 49 | Cholelithiasis (HP:0001081) | 2.53440126 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.53228267 |
| 51 | Absent frontal sinuses (HP:0002688) | 2.53108852 |
| 52 | Abnormality of the nasal mucosa (HP:0000433) | 2.51341111 |
| 53 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.49740929 |
| 54 | Joint hemorrhage (HP:0005261) | 2.46562244 |
| 55 | Episodic fever (HP:0001954) | 2.46441593 |
| 56 | Nemaline bodies (HP:0003798) | 2.45931388 |
| 57 | Malnutrition (HP:0004395) | 2.45291565 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43696031 |
| 59 | Orchitis (HP:0100796) | 2.40401112 |
| 60 | Abnormality of the peritoneum (HP:0002585) | 2.39151501 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.37721174 |
| 62 | Hypochromic anemia (HP:0001931) | 2.37124698 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.36958110 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36031954 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.34645615 |
| 66 | Chest pain (HP:0100749) | 2.34039640 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.33922482 |
| 68 | Nasal polyposis (HP:0100582) | 2.33674777 |
| 69 | Metaphyseal cupping (HP:0003021) | 2.33212103 |
| 70 | Thoracic kyphosis (HP:0002942) | 2.28973954 |
| 71 | Flat acetabular roof (HP:0003180) | 2.26814951 |
| 72 | Supranuclear gaze palsy (HP:0000605) | 2.25897574 |
| 73 | Abnormality of reticulocytes (HP:0004312) | 2.25621481 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.23440933 |
| 75 | Short femoral neck (HP:0100864) | 2.22768617 |
| 76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22572143 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.22572143 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.21464707 |
| 79 | Round ear (HP:0100830) | 2.20991309 |
| 80 | Encephalitis (HP:0002383) | 2.20334829 |
| 81 | Glomerulonephritis (HP:0000099) | 2.20062573 |
| 82 | Pustule (HP:0200039) | 2.19789672 |
| 83 | Polycythemia (HP:0001901) | 2.19679266 |
| 84 | Thickened calvaria (HP:0002684) | 2.19486078 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.18061486 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17090579 |
| 87 | Urticaria (HP:0001025) | 2.16833906 |
| 88 | Osteomyelitis (HP:0002754) | 2.15628596 |
| 89 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.15283550 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15001013 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.14296682 |
| 92 | Acanthocytosis (HP:0001927) | 2.13199818 |
| 93 | Type 1 muscle fiber predominance (HP:0003803) | 2.13001703 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12694675 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12694675 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12694675 |
| 97 | Abnormality of glycolysis (HP:0004366) | 2.12680505 |
| 98 | Alveolar cell carcinoma (HP:0006519) | 2.12216225 |
| 99 | Spondylolisthesis (HP:0003302) | 2.12051370 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 2.11301331 |
| 101 | Hyperactive renin-angiotensin system (HP:0000841) | 2.10061264 |
| 102 | Stomatitis (HP:0010280) | 2.09816056 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.09654724 |
| 104 | Purpura (HP:0000979) | 2.08459988 |
| 105 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07979969 |
| 106 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07979969 |
| 107 | Xanthomatosis (HP:0000991) | 2.06933643 |
| 108 | Increased IgE level (HP:0003212) | 2.06519481 |
| 109 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06384567 |
| 110 | Increased serum ferritin (HP:0003281) | 2.03992439 |
| 111 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.03578815 |
| 112 | Chronic diarrhea (HP:0002028) | 2.02514224 |
| 113 | Chronic bronchitis (HP:0004469) | 2.02152441 |
| 114 | Menorrhagia (HP:0000132) | 2.02075622 |
| 115 | Neurofibrillary tangles (HP:0002185) | 2.01711741 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00141242 |
| 117 | Osteolytic defects of the hand bones (HP:0009699) | 2.00141242 |
| 118 | Hepatoblastoma (HP:0002884) | 1.99732098 |
| 119 | Abnormality of the lumbar spine (HP:0100712) | 1.99129991 |
| 120 | Abnormality of the frontal sinuses (HP:0002687) | 1.97698411 |
| 121 | Epistaxis (HP:0000421) | 1.95387083 |
| 122 | Axonal loss (HP:0003447) | 1.95269188 |
| 123 | Anorexia (HP:0002039) | 1.94130390 |
| 124 | Cheilitis (HP:0100825) | 1.94065347 |
| 125 | Recurrent pneumonia (HP:0006532) | 1.93342225 |
| 126 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92661468 |
| 127 | Neuronal loss in central nervous system (HP:0002529) | 1.90396605 |
| 128 | Broad palm (HP:0001169) | 1.90205604 |
| 129 | Hypercholesterolemia (HP:0003124) | 1.88122439 |
| 130 | Restrictive lung disease (HP:0002091) | 1.87461857 |
| 131 | Meningitis (HP:0001287) | 1.86286807 |
| 132 | Disinhibition (HP:0000734) | 1.86060445 |
| 133 | Cupped ribs (HP:0000887) | 1.84920539 |
| 134 | Recurrent viral infections (HP:0004429) | 1.84710594 |
| 135 | Chronic otitis media (HP:0000389) | 1.84137983 |
| 136 | Disproportionate tall stature (HP:0001519) | 1.83814605 |
| 137 | Progressive visual loss (HP:0000529) | 1.83469399 |
| 138 | Hypobetalipoproteinemia (HP:0003563) | 1.83297736 |
| 139 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83100715 |
| 140 | Glomerulopathy (HP:0100820) | 1.80222387 |
| 141 | Osteomalacia (HP:0002749) | 1.80219277 |
| 142 | Ovoid vertebral bodies (HP:0003300) | 1.79117491 |
| 143 | Long palpebral fissure (HP:0000637) | 1.78117069 |
| 144 | Vasculitis (HP:0002633) | 1.77659028 |
| 145 | Sepsis (HP:0100806) | 1.77627718 |
| 146 | Stridor (HP:0010307) | 1.77293344 |
| 147 | Arterial thrombosis (HP:0004420) | 1.76885386 |
| 148 | Abnormal tarsal ossification (HP:0008369) | 1.76830604 |
| 149 | Widely patent fontanelles and sutures (HP:0004492) | 1.76584313 |
| 150 | Peripheral demyelination (HP:0011096) | 1.75821447 |
| 151 | Epiphyseal dysplasia (HP:0002656) | 1.74932602 |
| 152 | Abnormality of carpal bone ossification (HP:0006257) | 1.74423369 |
| 153 | Cerebral aneurysm (HP:0004944) | 1.74174887 |
| 154 | Abnormality of the gallbladder (HP:0005264) | 1.74059584 |
| 155 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73936530 |
| 156 | Pathologic fracture (HP:0002756) | 1.73731644 |
| 157 | Hemoptysis (HP:0002105) | 1.73079103 |
| 158 | Upper motor neuron abnormality (HP:0002127) | 1.72340936 |
| 159 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.71397457 |
| 160 | Acute hepatic failure (HP:0006554) | 1.71209455 |
| 161 | Difficulty running (HP:0009046) | 1.71193949 |
| 162 | Retrobulbar optic neuritis (HP:0100654) | 1.70841846 |
| 163 | Premature loss of primary teeth (HP:0006323) | 1.70234087 |
| 164 | Lymphopenia (HP:0001888) | 1.69713015 |
| 165 | Abnormal vertebral ossification (HP:0100569) | 1.68903795 |
| 166 | Small epiphyses (HP:0010585) | 1.67923300 |
| 167 | Abnormality of T cell physiology (HP:0011840) | 1.65638484 |
| 168 | Elevated alkaline phosphatase (HP:0003155) | 1.64704205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 3.47170976 |
| 2 | PKN2 | 3.42023049 |
| 3 | IRAK3 | 3.16501758 |
| 4 | IRAK4 | 3.03954703 |
| 5 | ERN1 | 2.96730508 |
| 6 | MAP2K3 | 2.92416703 |
| 7 | BLK | 2.87954936 |
| 8 | RIPK4 | 2.75523104 |
| 9 | FGFR4 | 2.60830202 |
| 10 | TTN | 2.54633604 |
| 11 | MAP4K1 | 2.21976323 |
| 12 | CSK | 2.07778944 |
| 13 | PRPF4B | 2.02959264 |
| 14 | TESK1 | 1.94339697 |
| 15 | TYK2 | 1.90132835 |
| 16 | TGFBR2 | 1.86551161 |
| 17 | FGR | 1.85433583 |
| 18 | STK10 | 1.82506810 |
| 19 | ZAP70 | 1.80835152 |
| 20 | MST4 | 1.78512009 |
| 21 | TRIB3 | 1.75432066 |
| 22 | CDK19 | 1.58366818 |
| 23 | MAP3K14 | 1.57881473 |
| 24 | BTK | 1.57134992 |
| 25 | FRK | 1.55329103 |
| 26 | GRK6 | 1.54172122 |
| 27 | PTK6 | 1.53800729 |
| 28 | TBK1 | 1.53392378 |
| 29 | YES1 | 1.47197923 |
| 30 | HCK | 1.46920630 |
| 31 | AKT3 | 1.45470969 |
| 32 | RIPK1 | 1.45302607 |
| 33 | JAK3 | 1.42274551 |
| 34 | ERBB3 | 1.42092041 |
| 35 | MAP3K3 | 1.39557580 |
| 36 | TRPM7 | 1.39031705 |
| 37 | CSF1R | 1.38904302 |
| 38 | FES | 1.37900875 |
| 39 | RET | 1.36748560 |
| 40 | PAK4 | 1.34850967 |
| 41 | MAP2K6 | 1.31114300 |
| 42 | FGFR3 | 1.26173138 |
| 43 | TAOK3 | 1.24110428 |
| 44 | MAP3K5 | 1.24105801 |
| 45 | SIK3 | 1.15127235 |
| 46 | SMG1 | 1.15118168 |
| 47 | PIK3CG | 1.14455266 |
| 48 | DYRK1B | 1.13945320 |
| 49 | JAK1 | 1.12123210 |
| 50 | CDK12 | 1.05738230 |
| 51 | DMPK | 1.05682344 |
| 52 | LRRK2 | 1.03240093 |
| 53 | MAP3K9 | 1.02958251 |
| 54 | KSR1 | 1.02586040 |
| 55 | CLK1 | 1.02545097 |
| 56 | PHKG2 | 1.02405167 |
| 57 | PHKG1 | 1.02405167 |
| 58 | PRKG2 | 1.01302859 |
| 59 | MARK2 | 0.98882053 |
| 60 | TAOK2 | 0.97936795 |
| 61 | TEC | 0.96125070 |
| 62 | NME1 | 0.95861379 |
| 63 | MAP3K12 | 0.95111132 |
| 64 | FLT3 | 0.94924732 |
| 65 | SYK | 0.93114490 |
| 66 | KSR2 | 0.93066244 |
| 67 | MAP2K4 | 0.91539715 |
| 68 | MAP3K1 | 0.91049899 |
| 69 | FGFR1 | 0.90338340 |
| 70 | ITK | 0.90024217 |
| 71 | TAOK1 | 0.89459217 |
| 72 | KIT | 0.88215512 |
| 73 | PTK2B | 0.83050022 |
| 74 | MAP3K13 | 0.82017480 |
| 75 | RPS6KA2 | 0.81812849 |
| 76 | PDK2 | 0.79280528 |
| 77 | CAMK1D | 0.79039174 |
| 78 | MATK | 0.78910085 |
| 79 | SIK2 | 0.77445309 |
| 80 | MARK3 | 0.77411387 |
| 81 | TYRO3 | 0.75442688 |
| 82 | TNK2 | 0.73863043 |
| 83 | EPHA3 | 0.73158832 |
| 84 | RAF1 | 0.73126984 |
| 85 | MAP3K7 | 0.70575226 |
| 86 | SGK3 | 0.70211397 |
| 87 | TNIK | 0.69568828 |
| 88 | BMX | 0.68133736 |
| 89 | MAP3K8 | 0.67816272 |
| 90 | BRD4 | 0.67127495 |
| 91 | MOS | 0.66301069 |
| 92 | JAK2 | 0.66204194 |
| 93 | ARAF | 0.66202531 |
| 94 | PRKD2 | 0.66159674 |
| 95 | PTK2 | 0.65800180 |
| 96 | PKN1 | 0.65631289 |
| 97 | CAMK1G | 0.65629055 |
| 98 | CAMKK2 | 0.65286000 |
| 99 | CAMKK1 | 0.65128845 |
| 100 | OBSCN | 0.64278943 |
| 101 | PDPK1 | 0.63405807 |
| 102 | WNK1 | 0.62272321 |
| 103 | LCK | 0.61903884 |
| 104 | MAP3K10 | 0.61821673 |
| 105 | MAP3K2 | 0.61534005 |
| 106 | ERBB2 | 0.61297731 |
| 107 | FYN | 0.57672591 |
| 108 | MAP3K6 | 0.57102880 |
| 109 | CDC42BPA | 0.56908233 |
| 110 | NEK9 | 0.56734555 |
| 111 | IKBKE | 0.56533701 |
| 112 | TESK2 | 0.56055239 |
| 113 | MAPKAPK2 | 0.55779918 |
| 114 | PDK3 | 0.55035946 |
| 115 | PDK4 | 0.55035946 |
| 116 | PDK1 | 0.54938399 |
| 117 | PRKCQ | 0.53954952 |
| 118 | STK24 | 0.52654608 |
| 119 | LYN | 0.51658623 |
| 120 | MAP3K11 | 0.51592298 |
| 121 | IKBKB | 0.50733545 |
| 122 | SIK1 | 0.50712606 |
| 123 | NEK2 | 0.48782719 |
| 124 | ICK | 0.48374554 |
| 125 | PRKCD | 0.46118469 |
| 126 | WNK4 | 0.45105209 |
| 127 | PRKCZ | 0.41527971 |
| 128 | TAF1 | 0.40340495 |
| 129 | DDR2 | 0.39032616 |
| 130 | CAMK4 | 0.38589915 |
| 131 | MAPK4 | 0.37974941 |
| 132 | BCKDK | 0.36589123 |
| 133 | MAPK12 | 0.36365603 |
| 134 | MAP2K2 | 0.36173794 |
| 135 | PRKAA2 | 0.35703734 |
| 136 | RPS6KL1 | 0.35577743 |
| 137 | RPS6KC1 | 0.35577743 |
| 138 | BRAF | 0.33794595 |
| 139 | CHUK | 0.33511275 |
| 140 | EGFR | 0.33503598 |
| 141 | RPS6KA6 | 0.33449501 |
| 142 | PRKCI | 0.32957776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63045812 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.30027072 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.12887727 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06413271 |
| 5 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.06302532 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02820387 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96669960 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 1.90104212 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84209573 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83365910 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.83155835 |
| 12 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.82229189 |
| 13 | Mineral absorption_Homo sapiens_hsa04978 | 1.73991750 |
| 14 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.73737729 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.71274110 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64343278 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63697948 |
| 18 | Phagosome_Homo sapiens_hsa04145 | 1.62649894 |
| 19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.59339942 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.59069730 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55089608 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.54880124 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54794505 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54079380 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49081399 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.47291803 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42248563 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41993003 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.39593088 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.30738600 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.25360745 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20873895 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20669906 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18839754 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18021007 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17782462 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17260561 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16521542 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16257649 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12235656 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.12058982 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11846575 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07582282 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06750407 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06670456 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.05686939 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.05168128 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04834802 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03784088 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.03510365 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01878867 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98409134 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95451961 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.95009842 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94831520 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94649036 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94038499 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93639430 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93574553 |
| 60 | Measles_Homo sapiens_hsa05162 | 0.93177259 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92089445 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91942833 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91858357 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91328119 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90514243 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89949301 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89117042 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88779005 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.86960291 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85670685 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83709278 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81711747 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81437276 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81409628 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80576286 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80472777 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79643726 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77000663 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75221144 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74580727 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.74337547 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73774759 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71987317 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.70927623 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70146256 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69848394 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.68446673 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68207696 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66704690 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66012038 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64443787 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64009323 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62788146 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62716408 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61048771 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59078683 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59012066 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58658887 |
| 99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58631759 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58382075 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57922341 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.57701145 |
| 103 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56928638 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56173892 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54583062 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54377316 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.54277636 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53284578 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.53183883 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50681466 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50680741 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50252790 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.50188576 |
| 114 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49420824 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49069309 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.48658083 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48648255 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48555002 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.48354522 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48046909 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46590287 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46476521 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46061282 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45602840 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45185856 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44746641 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42359786 |
| 128 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42303230 |

